28391514|t|Inflammatory and Oxidative Stress Markers in Experimental Allergic Asthma
28391514|a|Ovalbumin - induced allergic lung inflammation (ALI) is a condition believed to be mediated by cytokines, extracellular matrix remodeling, and redox imbalance. In this study, we evaluated pulmonary function together with inflammatory markers as interleukin-4 (IL-4), myeloperoxidase (MPO), eosinophil cells, and redox markers in the lungs of BALB/c mice after ovalbumin (OVA) sensitization and challenge. Our results showed an increase in bronchial hyperresponsiveness stimulated by methacholine (Mch), inflammatory cell influx, especially eosinophils together with an increase of high mobility group box 1 (HMGB1) and altered lipid peroxidation (LP) and antioxidant defenses in the OVA group compared to the control group (p â‰¤ 0.5). Thus, we demonstrated that OVA - induced ALI altered redox status concomitantly with impaired lung function, which was associated with HMGB1 expression and proteolytic remodeling. Taken together all results found here, we may suggest HMGB1 is an important therapeutic target for asthma, once orchestrates the redox signaling, inflammation, and remodeling that contribute to the disease development.
28391514	0	12	Inflammatory	T169	C0333348
28391514	17	33	Oxidative Stress	T049	C0242606
28391514	34	41	Markers	T201	C0005516
28391514	45	57	Experimental	T080	C1517586
28391514	58	73	Allergic Asthma	T047	C0155877
28391514	74	83	Ovalbumin	T116,T123	C0029923
28391514	86	93	induced	T169	C0205263
28391514	94	120	allergic lung inflammation	T047	C0002390
28391514	122	125	ALI	T047	C0002390
28391514	132	141	condition	T080	C0348080
28391514	169	178	cytokines	T116,T129	C0079189
28391514	180	200	extracellular matrix	T024	C0015350
28391514	201	211	remodeling	T038	C1820201
28391514	217	222	redox	T044	C0030012
28391514	223	232	imbalance	T184	C1397014
28391514	242	247	study	T062	C2603343
28391514	252	261	evaluated	T058	C0220825
28391514	262	280	pulmonary function	T042	C0231921
28391514	295	307	inflammatory	T169	C0333348
28391514	308	315	markers	T201	C0005516
28391514	319	332	interleukin-4	T116,T129	C0021758
28391514	334	338	IL-4	T116,T129	C0021758
28391514	341	356	myeloperoxidase	T116,T126	C0027021
28391514	358	361	MPO	T116,T126	C0027021
28391514	364	380	eosinophil cells	T025	C0014467
28391514	386	391	redox	T044	C0030012
28391514	392	399	markers	T201	C0005516
28391514	407	412	lungs	T023	C0024109
28391514	416	427	BALB/c mice	T015	C0025919
28391514	434	443	ovalbumin	T116,T123	C0029923
28391514	445	448	OVA	T116,T123	C0029923
28391514	450	463	sensitization	T040	C1325847
28391514	468	477	challenge	T059	C0022885
28391514	483	490	results	T169	C1274040
28391514	501	509	increase	T169	C0442805
28391514	513	542	bronchial hyperresponsiveness	T047	C0085129
28391514	543	553	stimulated	T070	C1948023
28391514	557	569	methacholine	T109,T121	C0600370
28391514	571	574	Mch	T109,T121	C0600370
28391514	577	589	inflammatory	T169	C0333348
28391514	590	601	cell influx	T043	C0007613
28391514	614	625	eosinophils	T025	C0014467
28391514	643	651	increase	T169	C0442805
28391514	655	680	high mobility group box 1	T116,T123	C0019796
28391514	682	687	HMGB1	T116,T123	C0019796
28391514	701	719	lipid peroxidation	T044	C0023775
28391514	721	723	LP	T044	C0023775
28391514	729	740	antioxidant	T121	C0003402
28391514	741	749	defenses	T077	C1880266
28391514	757	760	OVA	T116,T123	C0029923
28391514	761	766	group	UnknownType	C0681860
28391514	783	796	control group	T096	C0009932
28391514	835	838	OVA	T116,T123	C0029923
28391514	841	848	induced	T169	C0205263
28391514	849	852	ALI	T047	C0002390
28391514	861	866	redox	T044	C0030012
28391514	874	887	concomitantly	T079	C0521115
28391514	893	901	impaired	T169	C0221099
28391514	902	915	lung function	T039	C0035245
28391514	927	942	associated with	T080	C0332281
28391514	943	948	HMGB1	T116,T123	C0019796
28391514	949	959	expression	T045	C1171362
28391514	964	975	proteolytic	T044	C0597304
28391514	976	986	remodeling	T038	C1820201
28391514	1007	1014	results	T169	C1274040
28391514	1042	1047	HMGB1	T116,T123	C0019796
28391514	1054	1063	important	T080	C3898777
28391514	1064	1075	therapeutic	T169	C0302350
28391514	1076	1082	target	T169	C1521840
28391514	1087	1093	asthma	T047	C0004096
28391514	1100	1112	orchestrates	T080	C0205556
28391514	1117	1122	redox	T044	C0030012
28391514	1123	1132	signaling	T038	C3537152
28391514	1134	1146	inflammation	T046	C0021368
28391514	1152	1162	remodeling	T038	C3714634
28391514	1186	1193	disease	T047	C0012634
28391514	1194	1205	development	T169	C1527148